Biomarker for Homozygous Familial Hypercholesterolemia (BioHoFH)
NCT03198897 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new MS-based biomarker for the early and sensitive diagnosis of Homozygous familial Hypercholesterolemia from blood
Conditions
- Lipoprotein Lipase Deficiency
- Inborn Error of Lipid Metabolism
- Corneal Arcus
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 2 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-02-28
- Completion
- 2021-02-28
Countries
- Germany
- India
- Sri Lanka
Study Locations
More Related Trials
-
A PK Study to Assess the Drug-drug Interaction of a Strong CYP2C8 Inhibitor on Adagrasib
NCT05868356 ·Status: COMPLETED ·Phase: PHASE1
-
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
NCT07050433 ·Status: RECRUITING
-
Quantitative MRI for Myelofibrosis
NCT01973881 ·Status: RECRUITING
-
Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003
NCT01099267 ·Status: COMPLETED
-
Limbal Stem Cell Deficiency (LSCD) Treatment With Cultivated Stem Cell (CALEC) Graft
NCT02592330 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
NCT00899080 ·Status: COMPLETED
-
CEP-701 (Lestaurtinib) in Myelofibrosis
NCT00668421 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
CellCept/Iron Study: The Iron Ion-Mycophenolate Mofetil Chelation Complex Interaction in Renal Allograft Recipients
NCT00227045 ·Status: COMPLETED
-
S8809-S9800-S9911TM- Biological Markers in Patients With Follicular Lymphoma Treated on Clinical Trial SWOG-8809, SWOG-9800, or SWOG-9911
NCT00896922 ·Status: COMPLETED
-
Mobilization of Stem Cells With G-CSF and Mozobil in Patients With End Stage Liver Disease
NCT01711073 ·Status: UNKNOWN ·Phase: PHASE1
-
Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry
NCT01144780 ·Status: TERMINATED
-
Celecoxib in Preventing Cancer in Patients With Oral Leukoplakia and/or Head and Neck Dysplasia
NCT00052611 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides
NCT00002557 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon
NCT00176618 ·Status: TERMINATED ·Phase: NA
-
Celecoxib Inhibition of Aromatase Expression and Inflammation in Adipose Tissue of Obese Postmenopausal Women
NCT01901679 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Lurbinectedin in Patients With Advanced Gastrointestinal Malignancies With DNA Repair Mutations
NCT05229588 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
NCT06502171 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Analysis of Oral Mucositis in Patient's Undergoing Melphalan Conditioning and Autologous Stem Cell Transplant
NCT02589860 ·Status: WITHDRAWN
-
Does Maitake Mushroom Extract Enhance Hematopoiesis in Myelodysplastic Patients?
NCT01099917 ·Status: COMPLETED ·Phase: PHASE2
-
Etoposide and Celecoxib in Patients With Advanced Cancer
NCT00551005 ·Status: COMPLETED ·Phase: PHASE1
-
Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
NCT06159166 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
CEP-701 for PH-negative Myelofibrosis
NCT00494585 ·Status: COMPLETED ·Phase: PHASE2
-
CC-4047 in Treating Patients With Myelofibrosis
NCT00669578 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Research for Pathophysiology of Cancer Related Fatigue (CRF) and Chronic Fatigue (CFS/ME)
NCT03773003 ·Status: RECRUITING ·Phase: NA
-
Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma
NCT02839720 ·Status: COMPLETED ·Phase: PHASE2